Fulminant Myocarditis and Cardiogenic Shock Following COVID-19 Infection Versus COVID-19 Vaccination: A Systematic Literature Review.
Maya E GuglinAniekeme EtukChirag ShahOnyedika J IlonzePublished in: Journal of clinical medicine (2023)
In the first series to retrospectively assess fulminant myocarditis associated with COVID-19 infection versus COVID-19 vaccination, we found that both conditions had a similarly high mortality rate, while COVID-19 FM had a more malignant course with more symptoms on presentation, more profound hemodynamic decompensation (higher heart rate, lower blood pressure), more cardiac arrests, and higher temporary MCS requirements including VA-ECMO. In terms of pathology, there was no difference in most biopsies/autopsies that demonstrated lymphocytic infiltrates and some eosinophilic or mixed infiltrates. There was no predominance of young males in COVID-19 vaccine FM cases, with male patients representing only 40.9% of the cohort.
Keyphrases
- coronavirus disease
- heart rate
- sars cov
- blood pressure
- heart rate variability
- end stage renal disease
- respiratory syndrome coronavirus
- ejection fraction
- chronic kidney disease
- extracorporeal membrane oxygenation
- prognostic factors
- type diabetes
- peritoneal dialysis
- acute respiratory distress syndrome
- risk factors
- hypertensive patients
- intellectual disability
- liver failure
- hepatitis b virus
- sleep quality
- patient reported